NCT07553949Not yet recruiting
Leveraging Pharmacy Technicians to Advance the Reach of Modern Antiretroviral Therapy (PHARM ART) in Community Clinics
Source: ClinicalTrials.gov · Last updated 28 Apr 2026
Brief summary (registry, in English)
Long-acting injectable HIV medication is an important new innovation in HIV treatment, but complex delivery logistics have resulted in limited access for people with HIV (PWH). The goal of this study is to use clinic-based pharmacy technicians to improve delivery of long-acting injectable HIV medication at federally qualified health centers in Chicago. Participants at the community clinics may be invited to take part in study surveys or interviews. Participants at the community clinics will be part of an observational cohort.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 465 (estimated)
- First submitted
- 14 Apr 2026
- Start date
- Jan 2027
- Primary completion date
- Jan 2030
- Lead sponsor
- University of Chicago
- Diseases
- HIV
- NCT number
- NCT07553949
What you commit to
- Study type: Interventional
- Planned participants: 465
- From Jan 2027 to the primary completion date, Jan 2030
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Inability to provide informed consent due to cognitive deficits, active psychosis, or acute intoxication
Who the study is looking for
- Patients with HIV at implementation sites
- English or Spanish speaking
- Age 15 year and older
- Able to provide informed consent
Age in the registry: 15 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.